Skip to main content

Peer Review reports

From: Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus dexamethasone/prednisone for the treatment of multiple myeloma: an indirect-comparison Meta-analysis of randomised controlled trials

Original Submission
10 Nov 2020 Submitted Original manuscript
5 Jan 2021 Reviewed Reviewer Report
23 Mar 2021 Reviewed Reviewer Report
3 Apr 2021 Author responded Author comments - Wu Ye
Resubmission - Version 2
3 Apr 2021 Submitted Manuscript version 2
16 Jun 2021 Reviewed Reviewer Report
24 Jun 2021 Reviewed Reviewer Report
2 Jul 2021 Author responded Author comments - Wu Ye
Resubmission - Version 3
2 Jul 2021 Submitted Manuscript version 3
Publishing
5 Jul 2021 Editorially accepted
6 Sep 2021 Article published 10.1186/s12885-021-08588-9

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us